MedTrace Logo

Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut Recovery

NCT03477266 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2018-08-14

No results posted yet for this study

Summary

Giving women one day before and immediately after cesarean section a mouthly dissolving mosapride tablets 2every every 8 hours for maximum of 5 days ,or getting recovered gastrointestinal functions And assess preoperative gastrointestinal functions

Conditions

  • Prevention of Postoperative Ileus

Interventions

DRUG

Mosapride

Intake mouthly dissolving mosapride tablets in immediate post cesarean section

DRUG

Placebo Oral Tablet

Dummy identical tablets to mouthly dissolving mosapride tablets

Sponsors & Collaborators

  • Benha University

    lead OTHER

Principal Investigators

  • Ashraf N Elmantwe, MD · Benha University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-06-01
Completion
2018-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03477266 on ClinicalTrials.gov